已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Intravitreal Steroids Compared with Anti-VEGF Treatment for Diabetic Macular Edema

医学 黄斑水肿 眼科 不利影响 阿柏西普 视力 荟萃分析 置信区间 随机对照试验 眼压 临床试验 血管抑制剂 贝伐单抗 内科学 外科 化疗
作者
Nikhil S. Patil,Andrew Mihalache,Amin Hatamnejad,Marko M. Popovic,Peter J. Kertes,Rajeev H. Muni
出处
期刊:Ophthalmology Retina [Elsevier BV]
卷期号:7 (4): 289-299 被引量:24
标识
DOI:10.1016/j.oret.2022.10.008
摘要

Diabetic macular edema (DME) can be treated with either intravitreal anti-VEGF injections or intravitreal corticosteroid injections.Clinical relevance: We provide an updated meta-analysis of the comparative efficacy and safety of intravitreal steroids and anti-VEGF agents for DME. A systematic search was performed on Ovid MEDLINE, Embase, and Cochrane Controlled Register of Trials from January 2005 to November 2021. Inclusion criteria included published randomized clinical trial data comparing the efficacy and safety of intravitreal steroids versus anti-VEGF agents for DME. Nonrandomized, noncomparative, and non-English studies were excluded. Fourteen randomized clinical trials reporting on 827 eyes were included. Between these 2 treatments, our analysis revealed no significant difference in best-corrected visual acuity (BCVA) outcomes at 3 months (P = 0.11), 6 months (P = 0.21), 12 months (P = 0.24), and final follow-up (P = 0.91). Retinal thickness was significantly lower with steroid treatment at 3 months (P = 0.04), 6 months (P < 0.00001), and final follow-up (weighted mean difference = 39.99 μm; 95% confidence interval [CI] = 14.58,65.41; P = 0.002); however, there was no significant difference at 12 months (P = 0.18). Intravitreal anti-VEGF agents were associated with a lower incidence of intraocular pressure-related adverse events (risk ratio = 0.13; 95% CI = 0.05, 0.34; P < 0.00001). There was no significant difference between comparators for other adverse events, including cataract-related adverse events (P = 0.22). Overall, intravitreal steroid treatment for DME was associated with no significant differences in BCVA, a significantly lower retinal thickness, and a higher risk of intraocular pressure-related events. The certainty of evidence ranged from low to moderate and the analysis was limited by heterogeneity. Our results reinforce the importance of a continual reevaluation of the role of intravitreal steroids in DME management. Proprietary or commercial disclosure may be found after the references.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
fff发布了新的文献求助10
2秒前
共享精神的应助被xxh采纳,获得10
2秒前
科研通AI6.4的应助被米诺采纳,获得10
3秒前
mondesy1完成签到,获得积分20
3秒前
5秒前
彩色若菱完成签到,获得积分10
7秒前
砰砰完成签到 ,获得积分10
8秒前
秋风完成签到,获得积分0
9秒前
火星上无春完成签到 ,获得积分10
10秒前
fanx完成签到 ,获得积分20
10秒前
11秒前
ranran完成签到 ,获得积分10
11秒前
u484121发布了新的文献求助60
11秒前
12秒前
CodeCraft的应助被开放的小Q采纳,获得10
12秒前
111完成签到,获得积分10
12秒前
淡淡的志泽完成签到,获得积分10
15秒前
15秒前
16秒前
3921337477的应助被u181800采纳,获得60
16秒前
16秒前
言_完成签到 ,获得积分10
16秒前
18秒前
热爱学习发布了新的文献求助10
18秒前
小鹿不迷路完成签到 ,获得积分10
21秒前
热爱学习发布了新的文献求助10
21秒前
热爱学习发布了新的文献求助30
22秒前
dd发布了新的文献求助30
24秒前
26秒前
仁爱的觅海完成签到,获得积分10
26秒前
u181800发布了新的文献求助60
28秒前
zhongxia完成签到 ,获得积分10
29秒前
3921337477的应助被u831685采纳,获得60
33秒前
xiaojunsong完成签到 ,获得积分10
34秒前
34秒前
36秒前
曲聋五完成签到 ,获得积分0
37秒前
38秒前
炙热问芙完成签到,获得积分20
38秒前
39秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184917
求助须知:如何正确求助?哪些是违规求助? 9573843
关于积分的说明 21833352
捐赠科研通 7782304
什么是DOI,文献DOI怎么找? 3434429
关于科研通互助平台的介绍 2558581
邀请新用户注册赠送积分活动 2481082